These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9716933)

  • 21. [Neuroenhancement: doping for the brain].
    Bruhn C
    Dtsch Med Wochenschr; 2009 Oct; 134(40):p35. PubMed ID: 19790040
    [No Abstract]   [Full Text] [Related]  

  • 22. Dopaminergic system dysfunction in recreational dexamphetamine users.
    Schrantee A; Václavů L; Heijtel DF; Caan MW; Gsell W; Lucassen PJ; Nederveen AJ; Booij J; Reneman L
    Neuropsychopharmacology; 2015 Mar; 40(5):1172-80. PubMed ID: 25394786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term alterations in vulnerability to addiction to drugs of abuse and in brain gene expression after early life ethanol exposure.
    Barbier E; Pierrefiche O; Vaudry D; Vaudry H; Daoust M; Naassila M
    Neuropharmacology; 2008 Dec; 55(7):1199-211. PubMed ID: 18713641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brain imaging and the effects of caffeine and nicotine.
    Dager SR; Friedman SD
    Ann Med; 2000 Dec; 32(9):592-9. PubMed ID: 11209966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined effects of ethanol and cocaine on FOS-like protein and cocaethylene biosynthesis in the rat.
    Torres G; Horowitz JM
    Psychopharmacology (Berl); 1996 Nov; 128(1):105-14. PubMed ID: 8944413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cerebral perfusion impairment in a patient with toluene abuse.
    Ryu YH; Lee JD; Yoon PH; Jeon P; Kim DI; Shin DW
    J Nucl Med; 1998 Apr; 39(4):632-3. PubMed ID: 9544669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CNS recovery from cocaine, cocaine and alcohol, or opioid dependence: a P300 study.
    Bauer LO
    Clin Neurophysiol; 2001 Aug; 112(8):1508-15. PubMed ID: 11459691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The expanding role of imaging in prion disease.
    Taber KH; Cortelli P; Staffen W; Hurley RA
    J Neuropsychiatry Clin Neurosci; 2002; 14(4):371-6. PubMed ID: 12426406
    [No Abstract]   [Full Text] [Related]  

  • 29. Rewarding properties of some drugs studied by place preference conditioning.
    Biała G; Langwiński R
    Pol J Pharmacol; 1996; 48(4):425-30. PubMed ID: 9112683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug-induced neurobehavioral plasticity: the role of environmental context.
    Badiani A; Robinson TE
    Behav Pharmacol; 2004 Sep; 15(5-6):327-39. PubMed ID: 15343056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Addiction: making the connection between behavioral changes and neuronal plasticity in specific pathways.
    Wolf ME
    Mol Interv; 2002 Jun; 2(3):146-57. PubMed ID: 14993375
    [No Abstract]   [Full Text] [Related]  

  • 32. [Amphetamine abuse and drug interactions].
    Horwitz H; Skanning P; Askaa B; Jürgens G
    Ugeskr Laeger; 2014 Nov; 176(45):. PubMed ID: 25394841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Voluntary consumption of amphetamine, cocaine, ethanol and morphine by rats as influenced by a preceding period of forced drug intake and clozapine.
    Ufer M; Dadmarz M; Vogel WH
    Pharmacology; 1999 Jun; 58(6):285-91. PubMed ID: 10325573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved regional cerebral blood flow in chronic cocaine polydrug users treated with buprenorphine.
    Levin JM; Mendelson JH; Holman BL; Teoh SK; Garada B; Schwartz RB; Mello NK
    J Nucl Med; 1995 Jul; 36(7):1211-5. PubMed ID: 7790946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Individual and combined effects of ethanol and cocaine on intracellular signals and gene expression.
    Torres G; Horowitz JM
    Prog Neuropsychopharmacol Biol Psychiatry; 1996 May; 20(4):561-96. PubMed ID: 8843485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Compulsive drug-seeking behavior and relapse. Neuroadaptation, stress, and conditioning factors.
    Weiss F; Ciccocioppo R; Parsons LH; Katner S; Liu X; Zorrilla EP; Valdez GR; Ben-Shahar O; Angeletti S; Richter RR
    Ann N Y Acad Sci; 2001 Jun; 937():1-26. PubMed ID: 11458532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drugs of abuse and brain gene expression.
    Torres G; Horowitz JM
    Psychosom Med; 1999; 61(5):630-50. PubMed ID: 10511013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The involvement of accumbal glycine receptors in the dopamine-elevating effects of addictive drugs.
    Jonsson S; Adermark L; Ericson M; Söderpalm B
    Neuropharmacology; 2014 Jul; 82():69-75. PubMed ID: 24686030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The imaging of brain function. Positron emission tomography, single-photon emission computed tomography, and some prospects for magnetic resonance.
    Potchen EJ; Potchen MJ
    Invest Radiol; 1991 Mar; 26(3):258-65. PubMed ID: 2055732
    [No Abstract]   [Full Text] [Related]  

  • 40. Translating positron emission tomography studies in animals to stimulant addiction: promises and pitfalls.
    Caprioli D; Fryer TD; Sawiak SJ; Aigbirhio FI; Dalley JW
    Curr Opin Neurobiol; 2013 Aug; 23(4):597-606. PubMed ID: 23664005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.